BMRN
BioMarin Pharmaceutical Inc
$57.20
0.45 (0.78%) Today
0.02 (0.03%) After-hours
— up— down
Market Cap
$11.06B+4.1%
Revenue (TTM)
$3.17B+9.9%
Net Income (TTM)
$261.30M-49.0%
EPS (TTM)
1.35-49.0%
Shares Out
193.28M
193.28MP/E Ratio
41.34
41.34Forward P/E
12.71
12.71Open
$57.91
$57.91Previous Close
$57.67
$57.67Day Range
$56.43 – $57.92
$56.43 – $57.9252-Week Range
$49.26 – $66.28
$49.26 – $66.28Beta
0.25
0.25Volume
1.63M
1.63MAvg Volume
2.14M
2.14MAnalyst Rating
Buy
BuyExchange
NASDAQ NMS - GLOBAL MARKET
NASDAQ NMS - GLOBAL MARKETAbout BMRN
BioMarin Pharmaceutical Inc. is an American biotechnology company headquartered in San Rafael, California. It has offices and facilities in the United States, South America, Asia, and Europe. BioMarin's core business and research are in enzyme replacement therapies (ERTs). BioMarin was the first company to provide therapeutics for mucopolysaccharidosis type I, by manufacturing laronidase. BioMarin was also the first company to provide therapeutics for phenylketonuria (PKU).